The Obscure NIH Official Blocking Lower Drug Prices

Mark Rohrbaugh, a mid-level staffer at the National Institutes of Health, has consistently blocked the use of march-in rights to seize patents on high-cost drugs.


TAP depends on your support

We’ve said it before: The greatest threat to democracy from the media isn’t disinformation, it’s the paywall. When you support The American Prospect, you’re supporting fellow readers who aren’t able to give, and countering the class system for information. Please, become a member, or make a one-time donation, today. Thank you!